| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,961 |
1,761 |
$74K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,390 |
1,211 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
360 |
315 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
870 |
379 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
347 |
300 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
386 |
322 |
$4K |
| 99201 |
|
125 |
106 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
60 |
59 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
281 |
259 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
87 |
81 |
$567.46 |
| 36416 |
|
98 |
86 |
$342.36 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
73 |
57 |
$75.04 |
| 81002 |
|
12 |
12 |
$50.51 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
57 |
46 |
$29.23 |
| 99000 |
|
58 |
55 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
16 |
$0.00 |